期刊文献+

PSA三联疗法对缺血性脑卒中患者颈动脉结构及血流动力学的影响 被引量:2

Effect of PSA triple therapy on carotid structure and hemodynamics in patients with ischemic stroke
下载PDF
导出
摘要 目的探讨普罗布考、阿托伐他汀、阿司匹林(PSA)三联疗法对缺血性脑卒中患者颈动脉结构及血流动力学的影响。方法选择2016年1月至2017年3月收治的180例缺血性脑卒中患者为研究对象,采用随机数字表法分为PSA组、SA组、A组各60例,PSA组给予普罗布考、阿托伐他汀、阿司匹林联合治疗,SA组给予阿托伐他汀、阿司匹林治疗,A组给予阿司匹林治疗,随访6个月,比较两组血脂代谢、颈动脉结构与血流动力学指标。结果PSA组、SA组总胆固醇(TC)、甘油三脂(TG)、低密度脂蛋白胆固醇(LDL-C)均明显低于A组,高密度脂蛋白胆固醇(HDL-C)明显高于A组(P <0. 05),PSA组TG、TC、LDL-C均明显低于SA组,HDL-C明显高于SA组(P <0.05); PSA组、SA组颈动脉内-中膜厚度(IMT)、斑块面积明显小于A组,管腔直径明显大于A组(P <0. 05),PSA组IMT、斑块面积明显小于SA组,管腔直径明显大于SA组(P <0. 05); PSA组、SA组收缩期峰值血流速度(SV)、舒张期峰值血流速度(DV)均明显高于A组,阻力指数(RI)明显低于A组(P <0. 05),PSA组SV、DV明显低于PSA组,RI明显高于PSA组(P <0. 05)。结论 PSA三联疗法有助于调节缺血性脑卒中患者血脂代谢,改善颈动脉结构,提高颈动脉血流速度。 Objective To investigate the effects of combination therapy with probucol,atorvastatin and aspirin( PSA)on carotid structure and hemodynamics in patients with ischemic stroke. Methods 180 patients with ischemic stroke admitted from 2016-01 to 2017-03 were selected as subjects. They were randomly divided into PSA group,SA group and A group,60 cases in each group. PSA group was given probucol,atavastatin and aspirin were combined;group ASA was given atorvastatin and aspirin;group A was given aspirin. After 6 months of follow-up,blood lipid metabolism,carotid structure and hemodynamic parameters were compared between the two groups. Results Total cholesterol( TC),triglyceride( TG) and low density lipoprotein cholesterol( LDL-C) in PSA group and SA group were significantly lower than those in group A,and high density lipoprotein cholesterol( HDL-C) was significantly higher than that in group A( P < 0. 05). TG,TC and LDL-C in the PSA group were significantly lower than those in the SA group,and HDL-C was significantly higher than the SA group( P < 0. 05). The carotid intima-media thickness( IMT) and plaque area in the PSA group and the SA group were significantly smaller than those in the A group. The lumen diameter was significantly larger than that in the A group( P < 0. 05). The IMT and plaque area in the PSA group were significantly smaller than those in the SA group. The lumen diameter was significantly larger than that of the SA group( P < 0. 05). The peak systolic blood flow velocity( SV) and peak diastolic blood flow velocity( DV) in the PSA group and the SA group were significantly higher than those in the A group,and the resistance index( RI) was significantly lower than that in the A group( P < 0. 05). The SV and DV of the PSA group were significantly lower than those of the PSA group,and the RI was significantly higher than that of the PSA group( P < 0. 05). Conclusion PSA triple therapy can help regulate blood lipid metabolism,improve carotid structure and increase carotid blood flow velocity in patients with ischemic stroke.
作者 李仲光 刘晓亮 李世芳 张冀燕 闫振 鲁丽平 唐菊 LI Zhong-guang;LIU Xiao-liang;LI Shi-fang;ZHANG Ji-yan;YAN Zhen;LU Li-ping;TANG Ju(The Third People's Hospital of Baoji City,Baoji 721004,China)
出处 《延安大学学报(医学科学版)》 2019年第1期31-35,共5页 Journal of Yan'an University:Medical Science Edition
关键词 缺血性脑卒中 普罗布考 阿托伐他汀 颈动脉内-中膜厚度 血流速度 Ischemic stroke Probucol Atorvastatin Carotid intima-media thickness Blood flow velocity
  • 相关文献

参考文献9

二级参考文献132

  • 1陈奕鹏,宋国亮,刘立群,彭述文,赖党强.颈动脉粥样硬化斑块的影像学比较与缺血性脑卒中的相关性研究[J].中外医疗,2012,31(28):167-168. 被引量:3
  • 2中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010[J].中国医学前沿杂志(电子版),2010,2(4):50-59. 被引量:1819
  • 3苏健,徐冰.伴高血压的脑梗死老年患者血清高迁移率族蛋白B1、甲壳质酶蛋白40和可溶性CD40配体的表达及意义[J].中国老年学杂志,2014,34(10):2672-2674. 被引量:5
  • 4各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33024
  • 5Abul- Kasim K, Brizzi M, Petersson J. Hyperdense middle cerebral artery sign is an ominous prognostic marker despite optimal workflow. Acta Neurol Scan& 2010, 122:132-139.
  • 6Liu L, Wang D, Wong KS, Wang Y. Stroke and stroke care in China: huge burden, significant workload, and a national priority. Stroke, 2011, 42:3651-3654.
  • 7Wardlaw JM, Mielke O. Early signs of brain infarction at CT.Observer reliability and outcome after thrombolytie treatment: systematic review. Radiology, 2005, 235:444-453.
  • 8Agarwal P, Kumar S, Hariharan S, Eshkar N, Verro P, Cohen B, Sen S. Hyperdense middle cerebral artery sign: can it be used to select intra-arterial versus intravenous thrombolysis in acute ischemic stroke? Cerebrovasc Dis, 2004, 17:182-190.
  • 9Qureshi AI, Ezzeddine MA, Nasar A, Suri MF, Kirmani JF, Janjua N, Divani AA. Is IV tissue plasminogen activator beneficial in patients with hyperdense artery sign? Neurology, 2006, 66:1171-1174.
  • 10Chapman SN, Mehndiratta P, Johansen MC, McMurry TL, Johnston KC, Southerland AM. Current perspectives on the use of intravenous recombinant tissue plasminogen attivator (tPA) for treatment of acute ischemic stroke. Vasc Health Risk Manag, 2014, 10:75-87.

共引文献33127

同被引文献23

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部